FFD-17937-67968
3 vaccinations
4 coded responses
36 check-ins
4 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 591 / MT
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-31
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
-
2021-02-19
Survey response — day 42, dose 2MedDRA: Ageusia, Anosmia, Cough, Diarrhoea, Fatigue, Nasal congestion — Feeling: Fair · Be unable to workFree text: Cough, nasal congestion, decreased smell, decreased taste, mild fatigue, diarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Survey response — 3 months, dose 2MedDRA: COVID-19, Fatigue, Feeling abnormal, Headache, Insomnia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: COVID-19 starting Feb. 14, with subsequent PASC symptoms (fatigue, brain fog, headaches, insomnia).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-11
Survey response — 6 months, dose 2MedDRA: Abnormal dreams, Brain fog, Discomfort, Dyspnoea exertional, Fatigue, Headache, Poor quality sleep, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Daily brain pressure/headaches, daily brain fog/smog, fatigue, exertional dyspnea, restless sleep, vivid dreams, intermittent episodes of migratory mononeuralgiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-11
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-20
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-01
- 2021-10-02
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
- 2022-03-28
-
2022-09-27
Survey response — 12 months, dose 3MedDRA: Condition aggravated, Fatigue, Insomnia, Malaise, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Relapse of long COVID headache, fatigue, post-exertional malaise, and insomnia. (I was reinfected at the end of July.)MedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-09-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-28
Call successfulDoes not wish to fill out VAERS report
-
2022-09-28
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
Free text
Release 4 — day 42, dose 2
Symptoms: Cough, nasal congestion, decreased smell, decreased taste, mild fatigue, diarrhea
Release 7 — 3 months, dose 2
Symptoms: COVID-19 starting Feb. 14, with subsequent PASC symptoms (fatigue, brain fog, headaches, insomnia).
Release 9 — 6 months, dose 2
Symptoms: Daily brain pressure/headaches, daily brain fog/smog, fatigue, exertional dyspnea, restless sleep, vivid dreams, intermittent episodes of migratory mononeuralgia
Release 12 — 12 months, dose 3
Symptoms: Relapse of long COVID headache, fatigue, post-exertional malaise, and insomnia. (I was reinfected at the end of July.)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abnormal dreams | ✓ | ✓ | ✓ |
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Arthralgia | ○ | ○ | ○ |
| SD | Brain fog | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Discomfort | ✓ | ✓ | ✓ |
| SD | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Migraine | ○ | ○ | ○ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Poor quality sleep | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release